Cresco Labs management commentary: Lower tax expense drives narrower net loss in first nine months of 2026

• Cresco Labs management commentary linked third-quarter 2026 revenue of USD 172.78 million, up 4.8%, to Pennsylvania acquisitions and Ohio expansion.
• Gross margin fell to 46% from 48.1%, reflecting margin compression in higher-margin states.
• Adjusted EBITDA declined 12.3% to USD 34.9 million, primarily reflecting higher operating expenses, including salaries and office costs.
• Net loss narrowed to USD 14.53 million from USD 21.97 million, primarily because the prior-year debt-extinguishment loss did not recur.
• For the nine months ended September 30, 2026, net loss narrowed 68.3% to USD 16.18 million, primarily reflecting lower tax expense.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cresco Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001832928-26-000018), on November 06, 2026, and is solely responsible for the information contained therein.